AAAAAA

   
Results: 1-8 |
Results: 8
DEVELOPMENT OF IRREVERSIBLE EGFR TYROSINE KINASE INHIBITORS WITH ANTITUMOR-ACTIVITY AGAINST HUMAN TUMOR XENOGRAFTS
Authors: SMAILL JB DENNY WA FRY DW NELSON JM LEOPOLD WR VINCENT PW HOOK KE ELLIOTT WL BRIDGES AJ ZHOU H SHOWALTER HDH MCNAMARA DJ DOBRUSIN EM
Citation: Jb. Smaill et al., DEVELOPMENT OF IRREVERSIBLE EGFR TYROSINE KINASE INHIBITORS WITH ANTITUMOR-ACTIVITY AGAINST HUMAN TUMOR XENOGRAFTS, Annals of oncology, 9, 1998, pp. 415-415
SPECIFIC, IRREVERSIBLE INACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ERBB2, BY A NEW CLASS OF TYROSINE KINASE INHIBITOR
Authors: FRY DW BRIDGES AJ DENNY WA DOHERTY A GREIS KD HICKS JL HOOK KE KELLER PR LEOPOLD WR LOO JA MCNAMARA DJ NELSON JM SHERWOOD V SMAILL JB TRUMPPKALLMEYER S DOBRUSIN EM
Citation: Dw. Fry et al., SPECIFIC, IRREVERSIBLE INACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ERBB2, BY A NEW CLASS OF TYROSINE KINASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 95(20), 1998, pp. 12022-12027
DEVELOPMENT, STRUCTURE-ACTIVITY-RELATIONSHIPS AND ANTITUMOR-ACTIVITY OF A NOVEL CLASS OF SPECIFIC, IRREVERSIBLE EGFR TK INHIBITORS
Authors: SMAILL JB DENNY WA FRY DW NELSON JM LEOPOLD WR VINCENT PW PATMORE SJ ELLIOTT WL HOOK KE BRIDGES AJ ZHOU H SHOWALTER HDH MCNAMARA DJ DOBRUSIN EM
Citation: Jb. Smaill et al., DEVELOPMENT, STRUCTURE-ACTIVITY-RELATIONSHIPS AND ANTITUMOR-ACTIVITY OF A NOVEL CLASS OF SPECIFIC, IRREVERSIBLE EGFR TK INHIBITORS, British Journal of Cancer, 78, 1998, pp. 34-34
CLINICALLY RELEVANT SURAMIN DOSING REGIMEN IN MICE WITH NO EFFECTS AGAINST PC-3 PROSTATE XENOGRAFTS
Authors: ROBERTS BJ HOOK KE WHITFIELD LR CARTER CA ELLIOTT WL
Citation: Bj. Roberts et al., CLINICALLY RELEVANT SURAMIN DOSING REGIMEN IN MICE WITH NO EFFECTS AGAINST PC-3 PROSTATE XENOGRAFTS, Oncology Reports, 4(6), 1997, pp. 1361-1366
ENHANCED THERAPEUTIC EFFECT OF AMSALOG (CI-921) IN COMBINATION WITH CISPLATIN IN-VITRO AND IN-VIVO
Authors: ELLIOTT WL HOWARD CT ROBERTS BJ HOOK KE VINCENT PW CORBETT TH LEOPOLD WR
Citation: Wl. Elliott et al., ENHANCED THERAPEUTIC EFFECT OF AMSALOG (CI-921) IN COMBINATION WITH CISPLATIN IN-VITRO AND IN-VIVO, Oncology Reports, 3(6), 1996, pp. 1153-1159
CELLULAR-TRANSPORT OF CI-980
Authors: HOOK KE PRZYBRANOWSKI SA LEOPOLD WR
Citation: Ke. Hook et al., CELLULAR-TRANSPORT OF CI-980, Investigational new drugs, 14(4), 1996, pp. 341-347
INHIBITION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE BYPD153035 IN HUMAN A431 TUMORS IN ATHYMIC NUDE-MICE
Authors: KUNKEL MW HOOK KE HOWARD CT PRZYBRANOWSKI S ROBERTS BJ ELLIOTT WL LEOPOLD WR
Citation: Mw. Kunkel et al., INHIBITION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE BYPD153035 IN HUMAN A431 TUMORS IN ATHYMIC NUDE-MICE, Investigational new drugs, 13(4), 1995, pp. 295-302
ROLE OF A SMALL MOLECULAR-WEIGHT PHOSPHOPROTEIN IN THE MECHANISM OF ACTION OF CI-994 (N-ACETYLDINALINE)
Authors: RUMMEL SA KRAKER AJ STEINKAMPF RW HOOK KE KLOHS WD
Citation: Sa. Rummel et al., ROLE OF A SMALL MOLECULAR-WEIGHT PHOSPHOPROTEIN IN THE MECHANISM OF ACTION OF CI-994 (N-ACETYLDINALINE), International journal of cancer, 62(5), 1995, pp. 636-642
Risultati: 1-8 |